A detailed history of Voya Investment Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 19,792 shares of VNDA stock, worth $98,564. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,792
Previous 19,338 2.35%
Holding current value
$98,564
Previous $109,000 15.6%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.61 - $6.34 $2,092 - $2,878
454 Added 2.35%
19,792 $92,000
Q2 2024

Aug 14, 2024

SELL
$3.91 - $6.5 $926 - $1,540
-237 Reduced 1.21%
19,338 $109,000
Q1 2024

May 15, 2024

SELL
$3.47 - $4.61 $19,976 - $26,539
-5,757 Reduced 22.73%
19,575 $80,000
Q4 2023

Feb 14, 2024

SELL
$3.38 - $4.58 $204,233 - $276,741
-60,424 Reduced 70.46%
25,332 $106,000
Q3 2023

Nov 14, 2023

SELL
$4.28 - $6.57 $149,016 - $228,747
-34,817 Reduced 28.88%
85,756 $370,000
Q2 2023

Aug 14, 2023

BUY
$5.9 - $6.95 $5,846 - $6,887
991 Added 0.83%
120,573 $794,000
Q1 2023

May 15, 2023

BUY
$6.18 - $7.99 $22,618 - $29,243
3,660 Added 3.16%
119,582 $811,000
Q4 2022

Feb 14, 2023

BUY
$6.87 - $10.96 $217,009 - $346,204
31,588 Added 37.46%
115,922 $856,000
Q3 2022

Mar 03, 2023

SELL
$9.44 - $11.76 $298,190 - $371,474
-31,588 Reduced 27.25%
84,334 $833,000
Q3 2022

Nov 14, 2022

BUY
$9.44 - $11.76 $28,301 - $35,256
2,998 Added 3.69%
84,334 $833,000
Q2 2022

Aug 15, 2022

BUY
$9.31 - $11.84 $940 - $1,195
101 Added 0.12%
81,336 $886,000
Q1 2022

May 16, 2022

BUY
$10.84 - $16.55 $157,093 - $239,842
14,492 Added 21.71%
81,235 $919,000
Q4 2021

Feb 14, 2022

BUY
$15.69 - $21.14 $31,207 - $42,047
1,989 Added 3.07%
66,743 $1.05 Million
Q3 2021

Nov 15, 2021

BUY
$15.35 - $21.27 $19,724 - $27,331
1,285 Added 2.02%
64,754 $1.11 Million
Q2 2021

Aug 16, 2021

SELL
$15.71 - $21.51 $14,893 - $20,391
-948 Reduced 1.47%
63,469 $1.37 Million
Q1 2021

May 17, 2021

BUY
$13.42 - $20.28 $126,604 - $191,321
9,434 Added 17.16%
64,417 $968,000
Q4 2020

Feb 16, 2021

BUY
$9.77 - $13.81 $125,446 - $177,320
12,840 Added 30.47%
54,983 $722,000
Q3 2020

Nov 16, 2020

SELL
$9.32 - $12.02 $4,473 - $5,769
-480 Reduced 1.13%
42,143 $407,000
Q2 2020

Aug 14, 2020

SELL
$9.66 - $12.02 $76,903 - $95,691
-7,961 Reduced 15.74%
42,623 $488,000
Q1 2020

May 15, 2020

BUY
$7.5 - $16.8 $52,312 - $117,180
6,975 Added 15.99%
50,584 $524,000
Q4 2019

Feb 14, 2020

BUY
$12.38 - $17.47 $33,698 - $47,553
2,722 Added 6.66%
43,609 $716,000
Q3 2019

Nov 14, 2019

SELL
$12.27 - $15.79 $1,926 - $2,479
-157 Reduced 0.38%
40,887 $543,000
Q2 2019

Aug 14, 2019

BUY
$13.37 - $18.85 $8,530 - $12,026
638 Added 1.58%
41,044 $578,000
Q1 2019

May 15, 2019

BUY
$17.59 - $31.05 $329,847 - $582,249
18,752 Added 86.6%
40,406 $743,000
Q4 2018

Feb 14, 2019

BUY
$18.97 - $31.47 $20,108 - $33,358
1,060 Added 5.15%
21,654 $566,000
Q2 2018

Aug 14, 2018

BUY
$13.95 - $19.15 $6,640 - $9,115
476 Added 2.37%
20,594 $392,000
Q3 2017

Nov 14, 2017

BUY
$15.4 - $18.85 $309,817 - $379,224
20,118
20,118 $360,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $282M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.